This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Obstacles to EC generic drug approval increase healthcare costs. Pharmacoecon. Outcomes News 160, 12 (1998). https://doi.org/10.1007/BF03284857
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03284857